RECOMBIVAX HB

This brand name is authorized in Brazil, Canada, United States

Active ingredients

The drug RECOMBIVAX HB contains one active pharmaceutical ingredient (API):

1 Hepatitis B, purified antigen UNII XL4HLC6JH6 - HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN

Hepatitis B vaccine induces specific humoral antibodies against hepatitis B virus surface antigen (anti-HBsAg). Hepatitis B vaccine has been recognized as the first anti-cancer vaccine because it can prevent primary liver cancer. Read about Hepatitis B, purified antigen

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RECOMBIVAX HB Suspension for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BC01	Hepatitis B, purified antigen	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BC Hepatitis vaccines
Discover more medicines within J07BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525502601156415, 525502602152413
Country: CA	Health Products and Food Branch	Identifier(s): 02243676, 02245977
Country: US	FDA, National Drug Code	Identifier(s): 0006-4093, 0006-4094, 0006-4981, 0006-4992, 0006-4995, 50090-1716, 50090-1719, 50090-1849